SKYRIZI conc perf 600 mg/10ml flac 10 ml
7680689470016
CH-68947
L04AC18
07.15.0.
Reimbursement limitations:
SKYRIZI_600
Maladie de Crohn (dosages à 360 mg et 600 mg)
Seuls des médecins spécialistes en …
1 / 3
google
Details
- Product number
- 6894701
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- risankizumabum 600 mg, natrii acetas trihydricus corresp. natrium 2.09 mg, acidum aceticum glaciale, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 10 ml.
Articles (1)
Skyrizi 600 mg/10 ml, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
1
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
600.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.09 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 2343.30
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/12/2023
Authorization holder
AbbVie AG
6330 Cham
Authorization information
- Swissmedic authorization number
- 68947
- Drug name
- Skyrizi, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L04AC18
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 14/09/2023
- Authorization expiration date
- 13/09/2028
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SKYRIZI conc perf 600 mg/10ml flac 10 ml
- Description (DE)
- SKYRIZI Inf Konz 600 mg/10ml Durchstf 10 ml
- Market launch
- 14/09/2023
- Narcotic (BTM)
- No